Skip to content

Comparision of Long-duration, High-voltage Pulsed Radiofrequency and Standard Pulsed Radiofrequency in the treatment of thoracolumbar Postherpetic Neuralgia: A randomized, double-blind, controlled trial

Comparision of Long-duration, High-voltage Pulsed Radiofrequency and Standard Pulsed Radiofrequency in the treatment of thoracolumbar Postherpetic Neuralgia: A randomized, double-blind, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021575
Enrollment
Unknown
Registered
2019-02-28
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic Neuralgia

Interventions

Time Group:Parameters of Pulsed radiofrequency: Temperature: 42 degree C
Voltage: 45V
Pluse width: 2ms
Time: 900s
Voltage Group:Parameters of Pulsed radiofrequency: Temperature: 42 degree C
Voltage: the maximum voltage that the patients can tolerate
Control Group:Parameters of Pulsed radiofrequency: Temperature: 42 degree C
Time: 120s

Sponsors

Department of Pain Management, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Diagnosed with the criteria of postherpetic neuralgia, and the course of the disease was 1-3 months; 2) Aged 18-85 years old; 3) Preoperative VAS pain score is greater than 4; 4) Poor efficacy of oral medication or inability to tolerate oral medication; 5) Exclude other neuropathic pain; 6) Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with abnormal blood glucose control; 2) Patients with abnormal coagulation function, serious heart and lung diseases; 3) Patients who are not suitable to operate for bleeding and infection at the puncture site; 4) Patients who have previous mental illness, history of opioid abuse and local anesthetic allergy; 5) Patients who cannot cooperate with the treatment; 6) Patients with abnormal cognitive function.

Design outcomes

Primary

MeasureTime frame
VAS score and pain remission rate;

Secondary

MeasureTime frame
SF-36 score;

Countries

China

Contacts

Public ContactLi Song

West China Hospital, Sichuan University

song_li76@163.com+86 18980601501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026